to experience the full functionality of mail.com.
Can't access your account?
Keep me logged in!
Enhanced by Google
Johnson & Johnson
April 28, 2016
Abbott Labs to spend $19.3 billion to buy St. Jude Medical
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the ...
April 27, 2016
A day after credit downgrade by S&P, Exxon hikes dividend
A day after losing its cherished AAA credit rating partly due to billions paid to shareholders, Exxon Mobil is raising its ...
April 26, 2016
Stung by low oil prices, Exxon loses 'AAA' rating from S&P
Low oil prices have helped cost Exxon its pristine "AAA" credit rating from Standard & Poor's, a label it held for over six ...
April 19, 2016
Johnson & Johnson rides strong prescription sales in 1Q
Johnson & Johnson beat Wall Street expectations despite flat first-quarter profit, as higher sales of new prescription drugs ...
April 05, 2016
FDA approves 1st cheaper version of J&J's top drug Remicade
Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech ...
March 22, 2016
J&J expands project that aims to predict, prevent diseases
Johnson & Johnson has ramped up its ambitious project to learn how to predict who will develop particular diseases and find ...
February 23, 2016
Missouri jury awards $72M in Johnson & Johnson cancer suit
A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was ...
February 04, 2016
Johnson & Johnson, ViaCyte testing possible diabetes cure
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to ...
January 26, 2016
Johnson & Johnson beats 4Q profit views despite lower sales
Johnson & Johnson posted a 28 percent jump in fourth-quarter profit, beating Wall Street expectations, as the sale of part ...
January 21, 2016
Applications for US unemployment aid rise to 6-month high
The number of people seeking unemployment benefits rose last week to the highest level since July, though applications ...
January 19, 2016
Johnson & Johnson to cut about 3,000 jobs in medical devices
Johnson & Johnson said Tuesday that it plans to cut about 3,000 jobs over the next two years as the health care conglomerate ...
January 19, 2016
High court rejects appeal over $63M judgment in Motrin case
The Supreme Court has rejected an appeal from the manufacturer of Children's Motrin over a $63 million judgment awarded to ...
January 11, 2016
High court won't hear appeal over $124M drug penalty
The Supreme Court won't hear an appeal from a Johnson & Johnson subsidiary assessed more than $124 million in penalties for ...
November 20, 2015
FDA approves Takeda drug for blood cancer multiple myeloma
The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.
November 16, 2015
Johnson & Johnson multiple myeloma drug wins accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple ...
November 03, 2015
J&J, ViiV: 2 injections every month or 2 could control HIV
Preliminary testing of two long-acting injectable drugs indicates it might be possible to keep HIV at bay indefinitely with ...